Please try another search
Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in St Kilda, Australia.
Name | Age | Since | Title |
---|---|---|---|
Damon Rasheed | - | 2019 | CTO & Executive Director |
Christopher A. Ciavarra | 53 | 2018 | Member of Advisory board |
Kirsten Daru | 46 | 2018 | Member of Advisory Board |
Antanas Guoga | 50 | 2018 | Non-Executive Director |
Paul-Olivier DeHaye | - | - | Member of Advisory Board |
Ari Scharg | - | - | Member of Advisory Board |
Dimitrie Spiru Hugo Stephenson | 50 | 2023 | Board Advisor |
Mark Anthony Simari | 55 | 2023 | Non-Executive Director |
Saurabh Jain | - | 2023 | Interim CEO & Executive Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review